Credit: Octapharma. Balfaxar is a human plasma-derived, purified, virus inactivated and nanofiltered non-activated prothrombin complex concentrate. Balfaxar ® (prothrombin complex concentrate, ...
Patient Eilleen Corrigin has blood drawn at an anti-coagulation clinic at the Staten Island University Hospital in Staten Island, New York in this May 7, 2012, file photo. REUTERS/Allison Joyce/Files ...
To investigate an appropriate dosing strategy for 4F-PCC (Kcentra; CSL Behring) in obese patients, the authors conducted a retrospective analysis comparing the reversal of warfarin using adjusted ...
Hello. This is Dr. Sam Goldhaber from the Clotblog at theheart.org, speaking to you from Brigham and Women's Hospital and Harvard Medical School on the important topic of 4-factor prothrombin complex ...
The market for oral anticoagulants has advanced significantly since warfarin was essentially the lone option. Still, in some cases, the use of improved direct oral anticoagulants (DOACs) can provoke ...
More than 2.4 million people in the United States use warfarin to keep their blood from clotting after a heart attack, stroke or other serious thromboembolic complication. But using a blood thinner ...
Blood products, such as prothrombin complex concentrate, should be used only when the international normalized ratio (INR) is at least 1.5 and the patient has major bleeding (e.g., intracranial ...
PARAMUS, N.J., July 26, 2023 – Octapharma USA today announced that Balfaxar ® (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplex ®) has received U.S. Food and Drug ...
Please provide your email address to receive an email when new articles are posted on . Despite available guidelines, many questions remain about the best agent and dose for the urgent reversal of ...
Kcentra™ Is the First FDA-Approved 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in the U.S. CSL Behring announced today that the U.S. Food and Drug Administration (FDA) approved ...
There had been a lot of concern that 4F-PCC might be associated with a rebound thrombosis and an increased rate of myocardial infarction, pulmonary embolism, or stroke. That didn't happen. In fact, 4F ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback